Artelo Biosciences Inc (NASDAQ:ARTL) does about 71.42K shares in volume on a normal day but saw 26905217 shares change hands in the recent trading day. The company now has a market cap of 7.25M USD. Its current market price is $13.27, marking an increase of 95.43% compared to the previous close of $6.79. The 52 week high reached by this stock is $9.30 whilst the lowest price level in 52 weeks is $4.92.
The consensus objective for the share price is $36.00, suggesting that the stock has a potential upside of 63.14% over the period.
FactSet Research has provided data showing that 1 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 1 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Hold the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 12, 2021 when Ladenburg Thalmann initiated the stock to “Buy” and issued a price target of $7.
The current price level is 93.66%, 109.22%, and 102.95% away from its SMA20, SMA50, and SMA200 respectively, with the ARTL price moving below the 50-day SMA on current market day. Artelo Biosciences Inc (ARTL) stock is up 125.68% over the week and 117.90% over the past month. Its price is 64.38% year-to-date and 108.65% over the past year.
To reach the target analysts have set, the stock logically needs to grow 63.14 percent from here.
Outstanding shares total 3.28M with insiders holding 0.82% of the shares and institutional holders owning 2.64% of the company’s common stock. The company has a return on investment of -1366.39% and return on equity of -190.70%. The beta has a value of 1.05. Price to book ratio is 66.78.
